This event will cover innovations in advanced in vitro and in vivo disease modeling and how these advancements are accelerating drug discovery, personalized medicine and our understanding of complex disease mechanisms.

Antisense oligonucleotide (ASO) technology has accelerated drug discovery in the last few decades with several ASO-based drugs currently approved by FDA and many more being investigated in clinical trials.

Bringing together all speakers from the series, this dynamic panel will focus on fostering collaboration between researchers, facility managers and sustainability officers.

This event will focus on the latest progress in precision genome editing, novel delivery vectors, allogeneic cell therapies and the journey from laboratory research to clinical application, offering insights into the future of personalized medicine

Discover how to create a more sustainable future for scientific research. Join this webinar to learn practical strategies for minimizing your lab's environmental impact.

Focused on cutting-edge methods to reduce energy consumption in laboratories, enable green chemistry and AI/ML directed work flows.